Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

Mertigo SR sustained-release tablets

Dexa Medica

Ingredients in every sustained-release tablet

Betahistine 12 mg

Each package contains

10 strips of 10 sustained-release tablets

Dosage form

sustained-release tablet

Dosage formTablet; coated; sustained-release

Flavour

None

W.H.O. classification

N07C
N07C

A.T.C. Level 1

Anatomical Main group

N - Nervous system
N07C

A.T.C. Level 2

Therapeutic subgroup

N07 - Other Nervous System Drugs in ATC
N07C

A.T.C. Level 3

Pharmacological subgroup

N07C - Antivertigo Preparations

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Pregnancy

CAUTIONThis item may not be safe for use during pregnancy. Use with caution and after consultation with your doctor.

Lactation

CONSULT YOUR DOCTORSafety of this item for use during lactation has not been established. Please consult your doctor.

Indication

To relieve vertigo, dizziness which related to vestibular disorder in blood circulation disorder or Meniere’s syndrome, Meniere’s disease, and peripheral vertigo.

Dosage

18 YEARS OLD AND ABOVE
1 sustained-release tablet (12 mg of betahistine mesylate) twice daily, taken orally after each meal.

Betahistine mesylate sustained-release tablet must be swallowed whole and never crushed or chewed.